Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey

被引:49
|
作者
Dorman, Susan E. [1 ]
Chihota, Violet N. [2 ]
Lewis, James J. [2 ,3 ]
Shah, Maunank [1 ]
Clark, David [2 ]
Grant, Alison D. [3 ]
Churchyard, Gavin J. [2 ,3 ,4 ]
Fielding, Katherine L. [3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[4] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa
来源
PLOS ONE | 2012年 / 7卷 / 08期
基金
美国国家卫生研究院;
关键词
MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; RANDOMIZED-TRIAL; DIAGNOSIS; HIV; ASSAY; ERA;
D O I
10.1371/journal.pone.0043307
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Xpert MTB/RIF ("Xpert'') is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. Methodology/Principal Findings: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. Conclusion: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Xpert MTB/RIF test for tuberculosis
    Theron, Grant
    Peter, Jonny
    Dheda, Keertan
    LANCET, 2011, 378 (9790): : 481 - 481
  • [2] Evaluation of the Cepheid Xpert MTB/RIF assay
    Shinnick, Thomas M.
    Starks, Angela M.
    Alexander, Heather L.
    Castro, Kenneth G.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (01) : 9 - 22
  • [4] Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    Bodmer, Thomas
    Stroehle, Angelika
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (62):
  • [5] New Xpert® MTB/RIF test for tuberculosis diagnostics
    Rees, Jenaid
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (06) : 629 - 629
  • [6] Performance of Xpert MTB/RIF for the Diagnosis of Extrapulmonary Tuberculosis
    Kim, Soo-Kyung
    Chang, Jeonghyun
    Choi, Sang-Ho
    Sung, Heungsup
    Kim, Mi-Na
    CLINICAL LABORATORY, 2021, 67 (02) : 229 - 234
  • [7] Evaluation of Cepheid's Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting
    Lusiba, John K.
    Nakiyingi, Lydia
    Kirenga, Bruce J.
    Kiragga, Agnes
    Lukande, Robert
    Nsereko, Maria
    Ssengooba, Willy
    Katamba, Achilles
    Worodria, William
    Joloba, Moses L.
    Mayanja-Kizza, Harriet
    PLOS ONE, 2014, 9 (07):
  • [8] Revised Device Labeling for the Cepheid Xpert MTB/RIF Assay for Detecting Mycobacterium tuberculosis
    Gitterman, Steven
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (07): : 193 - 193
  • [9] Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan
    Sultanov, Sanjar
    Parpieva, Nargiza
    Mukhamedov, Kozim
    Turaev, Laziz
    Rakhmatulin, Rafis
    Gadoev, Jamshid
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [10] Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
    Horne, David J.
    Kohli, Mikashmi
    Zifodya, Jerry S.
    Schiller, Ian
    Dendukuri, Nandini
    Tollefson, Deanna
    Schumacher, Samuel G.
    Ochodo, Eleanor A.
    Pai, Madhukar
    Steingart, Karen R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (06):